Respective roles of the catalytic domains and C-terminal tail peptides in the oligomerization and secretory trafficking of human acetylcholinesterase and butyrylcholinesterase

FEBS Journal

Volumn 276, Issue 1, 2009, Pages 94-108

  Liang, Dong ^a,b   Blouet, Jean Philippe ^a   Borrega, Fernanda ^a   Bon, Suzanne ^a   Massoulié, Jean ^a  

^a ECOLE NORMALE SUPÉRIEURE   (France)

^b B326 Science Building   (China)

Author keywords

Acetylcholinesterase; Butyrylcholinesterase; Cysteines; Oligomers; Secretion

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; CYSTEINE; MONOMER; TETRAMER;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME RELEASE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; SEQUENCE ANALYSIS;

ACETYLCHOLINESTERASE; AMINO ACID SEQUENCE; ANIMALS; BUTYRYLCHOLINESTERASE; CATALYTIC DOMAIN; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; VERTEBRATES;

MAMMALIA; VERTEBRATA;

EID: 57649177578     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06756.x     Document Type: Article

References (63)

1. Massoulié J (2002) The origin of the molecular diversity and functional anchoring of cholinesterases. NeuroSignals 11, 130 143.
2. Massoulié J Bon S (2006) The C-terminal T peptide of cholinesterases: structure, interactions, and influence on protein folding and secretion. J Mol Neurosci 30, 233 236.
3. Belbeoc'h S, Massoulié J Bon S (2003) The C-terminal T peptide of acetylcholinesterase enhances degradation of unassembled active subunits through the ERAD pathway. EMBO J 22, 3536 3545.
4. Belbeoc'h S, Falasca C, Leroy J, Ayon A, Massoulié J Bon S (2004) Elements of the C-terminal t peptide of acetylcholinesterase that determine amphiphilicity, homomeric and heteromeric associations, secretion and degradation. Eur J Biochem 271, 1476 1487.
5. Falasca C, Perrier NA, Massoulié J Bon S (2005) Determinants of the t peptide involved in folding, degradation and secretion of acetylcholinesterase. J Biol Chem 280, 878 886.
6. Massoulié J, Bon S, Perrier N Falasca C (2005) The C-terminal peptides of acetylcholinesterase: cellular trafficking, oligomerization and functional anchoring. Chem Biol Interact 157-158, 3 14.
7. Bon S Massoulié J (1997) Quaternary associations of acetylcholinesterase. I Oligomeric associations of T subunits with and without the amino-terminal domain of the collagen tail. J Biol Chem 272, 3007 3015.
8. Blong RM, Bedows E Lockridge O (1997) Tetramerization domain of human butyrylcholinesterase is at the C-terminus. Biochem J 327, 747 757.
9. Krejci E, Thomine S, Boschetti N, Legay C, Sketelj J Massoulié J (1997) The mammalian gene of acetylcholinesterase-associated collagen. J Biol Chem 272, 22840 22847.
10. Perrier AL, Massoulié J Krejci E (2002) PRiMA, the membrane anchor of acetylcholinesterase in brain. Neuron 33, 275 285.
11. Bon S, Coussen F Massoulié J (1997) Quaternary associations of acetylcholinesterase; II. the polyproline attachment domain of the collagen tail. J Biol Chem 272, 3016 3021.
12. Noureddine H, Schmitt C, Liu WQ, Garbay C, Massoulié J Bon S (2007) Assembly of acetylcholinesterase tetramers by peptidic motifs from the proline-rich membrane anchor, PRiMA: competition between degradation and secretion pathways of heteromeric complexes. J Biol Chem 282, 3487 3497.
13. Noureddine H, Carvalho S, Schmitt C, Massoulié J Bon S (2008) Acetylcholinesterase associates differently with its anchoring proteins ColQ and PRiMA. J Biol Chem 283, 20722 20732.
14. Li H, Schopfer LM, Masson P Lockridge O (2008) Lamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers. Biochem J 411, 425 432.
15. Dvir H, Harel M, Bon S, Liu WQ, Vidal M, Garbay C, Sussman JL, Massoulié J Silman I (2004) Structural insight into tetramerization of the synaptic form of acetylcholinesterase: interaction of a polyproline II helix with four WWW motifs. EMBO J 23, 4394 4405.
16. Morel N, Leroy J, Ayon A, Massoulié J Bon S (2001) Acetylcholinesterase H and T dimers are associated through the same contact; mutations at this interface interfere with the C-terminal T peptide, inducing degradation rather than secretion. J Biol Chem 276, 37379 37389.
17. Simon S, Krejci E Massoulié J (1998) A four-to-one association between peptide motifs: four C-terminal domains from cholinesterase assemble with one proline-rich attachment domain (PRAD) in the secretory pathway. EMBO J 17, 6178 6187.
18. Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L Silman I (1991) Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253, 872 879.
19. Feng G, Krejci E, Molgo J, Cunningham JM, Massoulié J Sanes JR (1999) Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J Cell Biol 144, 1349 1360.
20. Perrier NA, Khérif S, Perrier AL, Krejci E, Dumas S, Mallet J Massoulié J (2003) Expression of PRiMA, the membrane anchor of acetylcholinesterase, in the mouse brain. Eur J Neurosci 18, 1837 1847.
21. Raveh L, Ashani Y, Levy D, De La Hoz D, Wolfe AD Doctor BP (1989) Acetylcholinesterase prophylaxis against oprganophosphate poisoning; quantirtative correlation between protection and blood-enzyme level in mice. Biochem Pharmacol 38, 529 534.
22. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV Lenz DE (1991) Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 259, 633 638.
23. Maxwell DM, Castro CA, De La Hoz DM, Gentry MK, Gold MB, Solana RP, Wolfe AD Doctor BP (1992) Protection of Rhesus monkeys against soman and prevention of performance decrement by preteatment with acetylcholinesterase. Toxicol Appl Pharmacol 115, 44 49.
24. Doctor BP, Blick DW, Caranto G, Castro CA, Gentry MK, Maxwell DM, Murphy MR, Schutz M, Waibel K Wolfe AD (1993) Cholinesterases as scavengers for organophosphorus compounds: protection of primate performance against soman toxicity. Chem Biol Interact 87, 285 293.
25. Maxwell DM, Saxena A, Gordon RK Doctor BP (1999) Improvements in scavenger protection against organophosphorus agents by modification of cholinesterases. Chem Biol Interact 119-120, 419 428.
26. Chitlaru T, Kronman C, Velan B Shafferman A (2001) Effect of human acetylcholinesterase subunit assembly on its circulatory residence. Biochem J 354, 613 625.
27. Doctor BP Saxena A (2005) Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interact 157-158, 167 171.
28. Cohen O, Kronman C, Chitlaru T, Ordentlich A, Velan B Shafferman A (2001) Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity. Biochem J 357, 795 802.
29. Chilukuri N, Parikh K, Sun W, Naik R, Tipparaju P, Doctor BP Saxena A (2005) Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesterase. Chem Biol Interact 157-158, 115 121.
30. Cohen O, Kronman C, Raveh L, Mazor O, Ordentlich A Shafferman A (2006) Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds. Mol Pharmacol 70, 1121 1131.
31. Cohen O, Kronman C, Lazar A, Velan B Shafferman A (2007) Controlled concealment of exposed clearance and immunogenic domains by site-specific polyethylene glycol attachment to acetylcholinesterase hypolysine mutants. J Biol Chem 282, 35491 35501.
32. Mazor O, Cohen O, Kronman C, Raveh L, Stein D, Ordentlich A Shafferman A (2008) Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase. Mol Pharmacol 74, 755 763.
33. Chilukuri N, Sun W, Naik RS, Parikh K, Tang L, Doctor BP Saxena A (2008) Effect of polyethylene glycol modification on the circulatory stability and immunogenicity of recombinant human butyrylcholinesterase. Chem Biol Interact 175, 255 260.
34. Massoulié J, Bon S, Rieger F Vigny M (1975) Molecular forms of acetylcholinesterase. Croat Chem Acta 47, 163 179.
35. Lockridge O, Bartels CF, Vaughan TA, Wong CK, Norton SE Johnson LL (1987) Complete amino acid sequence of human serum cholinesterase. J Biol Chem 262, 549 557.
36. Nachon F, Nicolet Y, Viguié N, Masson P, Fontecilla-Camps JC Lockridge O (2002) Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization. Eur J Biochem 269, 630 637.
37. Vigny M, Gisiger V Massoulié J (1978) 'Nonspecific' cholinesterase and acetylcholinesterase in rat tissues: molecular forms, structural and catalytic properties, and significance of the two enzyme systems. Proc Natl Acad Sci USA 75, 2588 2592.
38. Bon S, Dufourcq J, Leroy J, Cornut I Massoulié J (2004) The C-terminal t peptide of acetylcholinesterase forms an alpha helix that supports homomeric and heteromeric interactions. Eur J Biochem 271, 33 47.
39. Bon S, Vigny M Massoulié J (1979) Asymmetric and globular forms of acetylcholinesterase in mammals and birds. Proc Natl Acad Sci USA 76, 2546 2550.
40. Sternfeld M, Ming G, Song H, Sela K, Timberg R, Poo M Soreq H (1998) Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J Neurosci 18, 1240 1249.
41. Massoulié J, Perrier N, Noureddine H, Liang D Bon S (2008) Old and new questions about cholinesterases. Chem Biol Int 175, 30 44.
42. Layer PG, Alber R Rathjen FG (1988) Sequential activation of butyrylcholinesterase in rostral half somites and acetylcholinesterase in motoneurones and myotomes preceding growth of motor axons. Development 102, 387 396.
43. Layer PG (1990) Cholinesterases preceding major tracts in vertebrate neurogenesis. Bioessays 12, 415 420.
44. Layer PG, Weikert T Alber R (1993) Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism. Cell Tissue Res 273, 219 226.
45. Paraoanu LE Layer PG (2005) Mouse AChE binds in vivo to domain IV of laminin-1beta. Chem Biol Interact 157/158, 411 413.
46. Krejci E, Duval N, Chatonnet A, Vincens P Massoulié J (1991) Cholinesterase-like domains in enzymes and structural proteins: functional and evolutionary relationships and identification of a catalytically essential aspartic acid. Proc Natl Acad Sci USA 88, 6647 6651.
47. Grifman M, Galyam N, Seidman S Soreq H (1998) Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis. Proc Natl Acad Sci USA 95, 13935 13940.
48. Johnson G Moore SW (2000) Cholinesterases modulate cell adhesion in human neuroblastoma cells in vitro. Int J Dev Neurosci 18, 781 790.
49. Sharma KV, Koenigsberger C, Brimijoin S Bigbee JW (2001) Direct evidence for an adhesive function in the noncholinergic role of acetylcholinesterase in neurite outgrowth. J Neurosci Res 63, 165 175.
50. Mesulam M, Carson K, Price B Geula C (1992) Cholinesterases in the amyloid angiopathy of Alzheimer's disease. Ann Neurol 31, 565 569.
51. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C Garrido J (1996) Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16, 881 891.
52. Inestrosa NC Alarcon R (1998) Molecular interactions of acetylcholinesterase with senile plaques. J Physiol (Paris) 92, 341 344.
53. Diamant S, Podoly E, Friedler A, Ligumsky H, Livnah O Soreq H (2006) Butyrylcholinesterase attenuates amyloid fibril formation in vitro. Proc Natl Acad Sci USA 103, 8628 8633.
54. Podoly E, Bruck T, Diamant S, Melamed-Book N, Weiss A, Huang Y, Livnah O, Langermann S, Wilgus H Soreq H (2008) Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro. Neurodegener Dis 5, 232 236.
55. Greenfield SA Vaux DJ (2002) Parkinson's disease, Alzheimer's disease and motor neurone disease: identifying a common mechanism. Neuroscience 113, 485 492.
56. Cottingham MG, Hollinshead MS Vaux DJ (2002) Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide. Biochemistry 41, 13539 13547.
57. Cottingham MG, Voskuil JLA Vaux DJT (2003) The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers. Biochemistry 42, 10863 10873.
58. Bartels CF, Jensen FS, Lockridge O, van der Spek AF, Rubinstein HM, Lubrano T La Du BN (1992) DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am J Hum Genet 50, 1086 1103.
59. Altamirano CV, Bartels CF Lockridge O (2000) The butyrylcholinesterase K-variant shows similar cellular protein turnover and quaternary interaction to the wild-type enzyme. J Neurochem 74, 869 877.
60. Kunkel TA, Roberts JD Zakour RA (1987) Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 154, 367 382.
61. Morel N, Bon S, Greenblatt HM, Van Belle D, Wodak SJ, Sussman JL, Massoulié J Silman I (1999) Effect of mutations within the peripheral anionic site on the stability of acetylcholinesterase. Mol Pharmacol 55, 982 992.
62. Ellman GL, Courtney KD, Andres V Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7, 88 95.
63. Rost B (1996) PHD: predicting one-dimensional protein structure by profile-based neural networks. Methods Enzymol 266, 525 539.